Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumithra J Mandrekar

Showing results (91-100 of 157) with videos related to

Pageof 16
Sort By:
Cancer|October 21, 2010
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trialsNathan R Foster, Yingwei Qi, Qian Shi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Comparative bioavailability of sulindac in capsule and tablet formulationsJoel M Reid, Sumithra J Mandrekar, Elsa C Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung cancerAlex A Adjei, Julian R Molina, Sumithra J Mandrekar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancerYingwei Qi, Steven E Schild, Sumithra J Mandrekar, et al.
Cancer|June 2, 2007
The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancerSteven E Schild, Sumithra J Mandrekar, Aminah Jatoi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Endpoints in phase II trials for advanced non-small cell lung cancerSumithra J Mandrekar, Yingwei Qi, Shauna L Hillman, et al.
Radiology|February 8, 2005
CT screening for lung cancer: five-year prospective experienceStephen J Swensen, James R Jett, Thomas E Hartman, et al.
Cancer|April 30, 2009
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trialsNathan R Foster, Sumithra J Mandrekar, Steven E Schild, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2009
Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based studyPing Yang, Sumithra J Mandrekar, Shauna H Hillman, et al.
Blood Advances|January 24, 2024
Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphomaSarah C Rutherford, Jun Yin, Levi D Pederson, et al.
Pageof 16

Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
Cancer|October 21, 2010
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trialsNathan R Foster, Yingwei Qi, Qian Shi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Comparative bioavailability of sulindac in capsule and tablet formulationsJoel M Reid, Sumithra J Mandrekar, Elsa C Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung cancerAlex A Adjei, Julian R Molina, Sumithra J Mandrekar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancerYingwei Qi, Steven E Schild, Sumithra J Mandrekar, et al.
Cancer|June 2, 2007
The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancerSteven E Schild, Sumithra J Mandrekar, Aminah Jatoi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Endpoints in phase II trials for advanced non-small cell lung cancerSumithra J Mandrekar, Yingwei Qi, Shauna L Hillman, et al.
Radiology|February 8, 2005
CT screening for lung cancer: five-year prospective experienceStephen J Swensen, James R Jett, Thomas E Hartman, et al.
Cancer|April 30, 2009
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trialsNathan R Foster, Sumithra J Mandrekar, Steven E Schild, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2009
Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based studyPing Yang, Sumithra J Mandrekar, Shauna H Hillman, et al.
Blood Advances|January 24, 2024
Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphomaSarah C Rutherford, Jun Yin, Levi D Pederson, et al.
Pageof 16